Perigon Wealth Management’s Insmed INSM Stock Holding History

Perigon Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$33K	–	757
2020 Q4	$33K	Buy	+1,000	New	+$36.5K	﹤0.01%	870

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Perigon Wealth Management's INSM Position: Q1 2021 in Review

Perigon Wealth Management sold out of Insmed (INSM) in Q1 2021, closing a stake of 1,000 shares — an estimated $33K sold.

Perigon Wealth Management first reported a position in INSM in Q4 2020 and held it in 1 quarter. The position peaked at $33K in Q4 2020. 199 funds tracked by Wall St. Rank hold INSM as of Q1 2021.

Perigon Wealth Management reported no remaining Insmed position as of Q1 2021 after selling out during the quarter.
Perigon Wealth Management sold 1,000 Insmed shares in Q1 2021, an estimated $33K.
Perigon Wealth Management first reported a position in Insmed in Q4 2020 and held it in 1 quarter.
Perigon Wealth Management's Insmed position peaked at $33K in Q4 2020.
199 funds tracked by Wall St. Rank held Insmed as of Q1 2021.

Based on Perigon Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.